Summary & Overview

HCPCS J1729: Hydroxyprogesterone Caproate Injection, 10 mg

HCPCS Level II code J1729 denotes a 10 mg unit of hydroxyprogesterone caproate administered by injection. Nationally, this injectable progestin is used in clinical contexts where parenteral progesterone therapy is indicated, and accurate coding of J1729 is important for claims processing, benefit determination, and drug utilization tracking. Payers commonly encountered in national analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

This publication provides a concise overview of the clinical and billing context for J1729, outlines payer considerations, and highlights benchmarks and policy-relevant points readers should expect to see. Topics covered include typical sites of service (outpatient clinics and physician offices), service line implications for drug administration billing, and payer coverage patterns. The report also summarizes common modifiers and coding practices where available and identifies areas where input data were not provided.

Readers will gain a clear understanding of what J1729 represents, which payers to consider for national billing contexts, and which aspects of reimbursement and documentation commonly influence claim adjudication. Data not available in the input are noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ1729HCPCS Level IIhydroxyprogesterone caproateinjectable medicationdrug administrationoutpatient servicesmaternal-fetal medicinebilling and coding

Billing Code Overview

HCPCS Level II code J1729 describes an injection of hydroxyprogesterone caproate, not otherwise specified, 10 mg. This code represents a parenteral therapeutic medication administration for progesterone therapy delivered as an individual drug unit of 10 mg.

Service type: Therapeutic drug administration (injectable medication)

Typical site of service: Outpatient clinic, physician office, or infusion/medication administration setting

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A typical patient is a pregnant person with a history of one spontaneous singleton preterm birth between 20 0/7 and 36 6/7 weeks’ gestation who presents to a maternal-fetal medicine clinic or obstetric clinic for preventive therapy. The clinical workflow begins with confirmation of eligibility based on obstetric history, counseling about risks and benefits, and ordering of weekly intramuscular injections of J1729 (hydroxyprogesterone caproate) 10 mg. Administration typically occurs in an outpatient clinic, ambulatory infusion center, or physician office by a registered nurse or licensed medical assistant trained in intramuscular injections. Documentation includes indication, informed consent, site of injection, lot number, dosage, date/time, and any immediate adverse reaction. Patients receive injections weekly from 16–20 weeks’ gestation through 36 weeks’ gestation per standard protocols. Typical monitoring includes assessment for injection-site reaction, allergic response, and interval obstetric follow-up; urgent evaluation is arranged for signs of preterm labor or medication-related adverse events.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier used / standard billing	Use when no special circumstances apply to the service.
`22`	Increased procedural services	Use when the service required substantially greater effort, e.g., complex counseling or medically complicated injection sessions.
`23`	Unusual anesthesia	Rarely applicable; use only if unusual anesthesia related to the injection is required.
`52`	Reduced services	Use when the full service was not performed as described (e.g., partial dose administered).
`53`	Discontinued procedure	Use if injection session was started but discontinued for clinical reasons before administration.
`62`	Two surgeons	Not typically applicable; use only if two practitioners are medically necessary for administration.
`78`	Return to OR for related procedure during postoperative period	Not typically applicable; use only if an operative intervention related to injection complications occurs.
`80`	Assistant at surgery	Not applicable for routine injections; use only if an assistant’s role is billable and defined by payer.
`82`	Assistant (when qualified resident not available)	Rarely applicable; use per payer rules when an assistant is required and resident not available.
`AS`	Physician services in ambulatory surgery center	Use when billing from an ambulatory surgery center setting as required by the payer.
`CO`	Services related to a clinical trial (outside the 100-day global period)	Use when the injection is part of a clinical trial and payer requires CO modifier.
`CQ`	Service performed as part of a clinical trial (investigational device exemption)	Use per trial documentation requirements when applicable.
`QK`	Medical direction of two, three, or four concurrent anesthesia procedures	Not generally applicable; include only if anesthesia services meet criteria and affect billing.

Taxonomy Code	Specialty	Notes
`2080S00000X`	Obstetrics & Gynecology	Maternal-fetal medicine and general OB/GYN commonly prescribe and administer `J1729`.
`207R00000X`	Maternal-Fetal Medicine	High-risk pregnancy specialists who manage recurrent preterm birth prevention.
`364A00000X`	Infusion Therapy	Nurses and infusion clinics that administer intramuscular or injection therapies in outpatient settings.
`163W00000X`	Nurse Practitioner	NPs in obstetrics clinics who may order and administer injections under scope of practice.
`207P00000X`	Family Medicine	Family physicians providing prenatal care and administration of preventive injections.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`O09.513`	Supervision of pregnancy with history of preterm labor, third trimester	Indicates high risk for recurrent preterm birth; common indication for progesterone therapy.
`O09.511`	Supervision of pregnancy with history of preterm labor, first trimester	Early prenatal supervision for patients with prior preterm birth who may start therapy.
`O09.512`	Supervision of pregnancy with history of preterm labor, second trimester	Reflects ongoing monitoring and justification for preventive `J1729` injections.
`O60.1`	Preterm spontaneous labor with intact membranes	Relevant when documenting prior preterm labor history that justifies prophylactic therapy.
`Z87.430`	Personal history of complicated pregnancy due to preterm delivery	Used to document past obstetric history that supports use of hydroxyprogesterone caproate.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly billed when `J1729` is administered as an intramuscular injection in an outpatient setting.
`99401`	Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (approx. 15 minutes)	Used for documented counseling about preterm birth prevention and risks/benefits of progesterone therapy; select based on payer rules.
`99070`	Supplies and materials (e.g., bandages, syringes) provided by the physician over and above those usually included with the office visit	Use if billing for additional supplies related to injection when payer allows separate supply billing.
`99000`	Handling and/or conveyance of a specimen for transfer from the physician's office to a laboratory	Occasionally used if labs (e.g., pregnancy-related testing) are sent in conjunction with the injection visit.
`59400`	Routine obstetric care including antepartum care, vaginal delivery (with or without episiotomy) and postpartum care	Represents global obstetric care; use considerations needed when billing separate injections within global maternity package.